Expanding into the South American market? Brazil’s HOSPITALAR 2026—South America’s No. 1 event—is your must‑attend first stop.

As the largest and most authoritative healthcare event in South America, HOSPITALAR has, since its inception, been committed to fostering global exchanges in medical technology, driving product innovation, and promoting market collaboration, making it an indispensable platform for medical companies seeking to enter the Latin American market.

Author:

Exhibition Overview

Organized by Informa Markets, a world-leading exhibition organizer The 31st Brazil International Medical Equipment Exhibition (HOSPITALAR 2026), will be held on May 19–22, 2026 It was grandly held at the São Paulo Expo in Brazil. As the largest and most authoritative healthcare event in South America, HOSPITALAR has, since its inception, been committed to fostering global exchanges in medical technology, driving product innovation, and promoting market collaboration, making it an indispensable platform for medical companies seeking to enter the Latin American market.

This year’s exhibition covers the entire industry chain, including medical devices and instruments, diagnostic equipment, surgical and emergency‑care supplies, medical dressings and consumables, rehabilitation and physiotherapy products, digital health systems, laboratory equipment, pharmaceutical machinery, home‑healthcare products, and medical IT solutions. In addition to in‑person displays, the event will host numerous high‑level conferences, innovation launch events, and industry forums, spotlighting cutting‑edge medical technologies and market trends.

PART.01

Previous exhibition data

Exhibition Size: A total of over 1,270 brands from 32 countries and regions participated in the exhibition, with Chinese exhibitors numbering 388.

Professional Audience: The exhibition drew 85,000 professional visitors from 55 countries and regions. Notably, 92% of surveyed attendees expressed a clear intention to attend the 2026 edition.

Side events: Concurrently with the conference, more than 400 hours of professional academic sessions and forums were held, including the Home Care Conference, the International Digital Health Summit, the Rehabilitation Conference, and the Supply Chain Forum, bringing together over 900 industry speakers from around the world and attracting more than 5,000 attendees.

PART.02

Market Overview and Analysis

As the largest economy in South America, Brazil has a population of 213 million, and its medical device market continues to expand. Driven by both policy initiatives and market demand, this environment offers promising prospects for businesses:

Demographic changes

According to projections by the Brazilian Institute of Geography and Statistics (IBGE), by 2030, the proportion of the population aged 65 and over will exceed 18%, leading to a substantial increase in demand for geriatric disease management, home care services, and chronic disease monitoring devices.

National Health Strategy

The Brazilian government has launched the National Strategy for the Development of the Health Economy and Industrial Complex, setting a clear target to achieve 30% domestic production of basic medical equipment by 2026, thereby creating significant opportunities for foreign companies in areas such as manufacturing partnerships, technology transfer, and direct investment.

Telemedicine Expansion

The government plans to connect 30% of public hospitals nationwide to a unified telemedicine platform by 2026, driving rapid growth in the remote monitoring devices and digital health solutions market; the related market size is expected to exceed US$1.8 billion.

China–Brazil cooperation continues to deepen.

China has remained Brazil’s largest trading partner for many consecutive years. In 2024, bilateral trade between the two countries reached US$188.17 billion, up 3.56% year on year. In the first half of 2025, bilateral trade totaled US$83.37 billion, maintaining a steady growth trend.

Financial settlement convenience

The renewed local-currency swap agreement between China and Brazil, with a scale of RMB 190 billion/R$157 billion, has effectively reduced exchange-rate risks and transaction costs in bilateral trade, and is expected to cut financial costs for medical-device transactions by 15%–20%.

PART.03

Booth reservations are now open~